Atomo Diagnostics Company
%20.jpg)
Atomo Diagnostics design and manufactures blood-based, lateral flow rapid diagnostic test (RDT) devices.
%20.jpg)
Headquarters:
Leichhardt, New South Wales, Australia
Funding Status:
IPO
Employee Number:
11-50
Estimated Revenue:
$10M to $50M
Last Funding Type:
Convertible Note
Technology:
P4 Medicine
Last Funding Date:
2017-02-01
Founded Date:
2010-01-01
Industry:
Biotechnology, Health Care, Manufacturing, Medical Device